Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.82 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL21988052 | 1.00 | LMNA (0.82) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL334464 | 1.00 | — | — | |
| Glycerin SCHEMBL9130517 | 1.00 | LMNA (0.82) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL2305273 | 1.00 | LMNA (0.82) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL3725402 | 1.00 | LMNA (0.82) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL27710119 | 0.96 | — | — | |
| Glycerin SCHEMBL10457130 | 0.92 | LMNA (0.69) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL11352453 | 0.92 | LMNA (0.69) | LMNAALDH1A1THRBTDP1L3MBTL1 | |
| Glycerin SCHEMBL797 | 0.91 | — | — | |
| Glycerin SCHEMBL5610362 | 0.91 | LMNA (1.00) | LMNAALDH1A1THRBTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024015959-A1 | METHODS OF MAKING AND USING CONTACT LENSES INCLUDING MEDICAMENTS AND STABILIZERS OF LABILE COMPONENTS SUCH AS DRUGS | DOSHI PRAFUL (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20220218600-A1 | MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING ENHANCING COMFORT, ENHANCING DRUG PENETRATION, AND TREATMENT OF MYOPIA | MEDIPRINT OPHTHALMICS INC. | 2022-07-14 | — | — | US | disclosed |
| US-11234927-B2 | Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia | MEDIPRINT OPHTHALMICS INC. | 2022-02-01 | — | — | US | disclosed |
| US-20210346285-A1 | MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING ENHANCING COMFORT, ENHANCING DRUG PENETRATION, AND TREATMENT OF MYOPIA | MEDIPRINT OPHTHALMICS INC. | 2021-11-11 | — | — | US | disclosed |
| US-11077054-B2 | Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia | MEDIPRINT OPHTHALMICS INC. | 2021-08-03 | — | — | US | disclosed |
| US-20210163668-A1 | ELECTROACTIVE POLYMERS | BASF SE (DE) | 2021-06-03 | — | — | US | disclosed |
| US-20210038509-A1 | MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING ENHANCING COMFORT, ENHANCING DRUG PENETRATION, AND TREATMENT OF MYOPIA | MEDIPRINT OPHTHALMICS INC. | 2021-02-11 | — | — | US | disclosed |
| EP-3039074-B1 | BLOW MOLDING METHOD FOR FORMING CONTAINERS USING A HIGHLY MODIFIED POLYESTERS | DISCMA AG (CH) | 2020-12-02 | — | — | EP | disclosed |
| US-10842740-B2 | Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia | MEDIPRINT OPHTHALMICS INC. | 2020-11-24 | — | — | US | disclosed |
| US-20200268649-A1 | MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING ENHANCING COMFORT, ENHANCING DRUG PENETRATION, AND TREATMENT OF MYOPIA | MEDIPRINT OPHTHALMICS INC. | 2020-08-27 | — | — | US | disclosed |
| US-20030009949-A1 | Abrasive article with optimally oriented abrasive particles and method of making the same | 3M INNOVATIVE PROPERTIES COMPANY | 2003-01-16 | — | — | US | disclosed |
| WO-2002068154-A1 | ABRASIVE ARTICLE WITH OPTIMALLY ORIENTED ABRASIVE PARTICLES AND METHOD OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-09-06 | — | — | WO | disclosed |
| US-20020030788-A1 | Tinted lenses and methods of manufacture | DOSHI PRAFUL (US) | 2002-03-14 | — | — | US | disclosed |
| US-6315410-B1 | Tinted lenses and methods of manufacture | DOSHI, PRAFUL | 2001-11-13 | — | — | US | disclosed |
| US-5158832-A | Lenses from polymeric derivatives of acrylic and methacrylic acids | CESKOSLOVENSKA AKADEMIE VED (CS) | 1992-10-27 | — | — | US | disclosed |
| US-5021263-A | Whole or partial etherified 1,3-dialkyl-4,5-dihydroxy-imidazolidinone; shrink resistace | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
| US-4478894-A | ISOCYANATE COMPONENT IS OXADIAZINETRIONE RING FROM REACTION OF BISISOCYANATOMETHYL/CYCLOHEXANE AND CARBON DIOXIDE | TAKEDA CHEMICAL INDUSTRIES, INC. (JP) | 1984-10-23 | — | — | US | disclosed |
| US-4346185-A | Process for the production of alkali metal unsaturated polyester silicate resinous products | BLOUNT DAVID H | 1982-08-24 | — | — | US | disclosed |
| US-4293480-A | Urethane binder compositions for no-bake and cold box foundry application utilizing isocyanato-urethane polymers | ASHLAND OIL, INC. (US) | 1981-10-06 | — | — | US | disclosed |
| US-4110286-A | Stable polyurethane latices, emulsifiable prepolymers therefor and methods of making the same | ALCOLAC INC. (US) | 1978-08-29 | — | — | US | disclosed |